According to Chugai Pharmaceutical's latest financial reports the company has a price-to-book ratio of 4.70.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 4.57 | -11.56% |
2021-12-31 | 5.17 | -44.01% |
2020-12-31 | 9.23 | 42.83% |
2019-12-31 | 6.46 | 40.04% |
2018-12-31 | 4.61 | 1.64% |
2017-12-31 | 4.54 | 59.51% |
2016-12-31 | 2.85 | -22.88% |
2015-12-31 | 3.69 | 36.47% |
2014-12-31 | 2.70 | 22.4% |
2013-12-31 | 2.21 | 20.51% |
2012-12-31 | 1.83 | 22.9% |
2011-12-31 | 1.49 | -17.31% |
2010-12-31 | 1.80 | -17.17% |
2009-12-31 | 2.18 |